DNLI - Company ID 0001714899
As of 2026-07-09, Denali Therapeutics Inc. (DNLI) has a market capitalization of $4.32 B, making it the #1534 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-07-09 | $4.32 B |
| 2026-07-08 | $4.07 B |
| 2026-07-07 | $4.13 B |
| 2026-07-06 | $4.09 B |
| 2026-07-05 | $4.10 B |
| 2026-07-04 | $4.10 B |
| 2026-07-03 | $4.10 B |
| 2026-07-02 | $4.10 B |
| 2026-07-01 | $4.09 B |
| 2026-06-30 | $4.08 B |
| 2026-06-29 | $4.11 B |
| 2026-06-28 | $4.06 B |
As of 2026-07-09, Denali Therapeutics Inc. (DNLI) has a market capitalization of $4.32 B, making it the #1534 most valuable US-listed company.
Denali Therapeutics Inc. is the #1534 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-06-27 | $4.06 B |
| 2026-06-26 | $4.06 B |
| 2026-06-25 | $3.92 B |
| 2026-06-24 | $3.94 B |
| 2026-06-23 | $3.93 B |
| 2026-06-22 | $3.82 B |
| 2026-06-21 | $3.70 B |
| 2026-06-20 | $3.70 B |
| 2026-06-19 | $3.70 B |
| 2026-06-18 | $3.70 B |
| 2026-06-17 | $3.73 B |
| 2026-06-16 | $3.51 B |
| 2026-06-15 | $3.50 B |
| 2026-06-14 | $3.44 B |
| 2026-06-13 | $3.44 B |
| 2026-06-12 | $3.42 B |
| 2026-06-11 | $3.40 B |
| 2026-06-10 | $3.27 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.